Delivery Order SPE2DB24D2205-SPE2DB25FEATJ
Award Date
4/9/25
Potential Completion Date
4/30/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,151.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of IMBRUVICA 280 MG TABLET 28S. The contract has a ceiling value of $15,151.52 and runs from January 24, 2025 to February 14, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $45,454.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, and has a period of performance through March 28, 2025. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of IMBRUVICA 140 MG TABLET 28S. The $7,575.75 fixed-price contract has a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves as a primary vehicle for providing...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 280 MG TABLET 28S, with a ceiling value of $15,151.52 and a period of performance through July 8, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $15,151.52 and a period of performance ending on July 15, 2025. The contract is not set aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
The federal contract award, valued at $7,575.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for IMBRUVICA 420 MG TABLET 28S, with an ultimate completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,645.34 firm fixed price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication, with a period of performance through August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999, for the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,151.50, is for the delivery of IMBRUVICA 140 MG TABLET 28S, a specialty medication. It is a firm-fixed-price delivery order contract that runs through April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product. The contract is not set aside and has a ceiling value of $15,151.52. It is a firm fixed-price contract with a completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...